Senescent human fibroblasts have increased FasL expression and impair the tumor immune response

Monica Cruz¹Joshua Dulong¹Georgio Mansour Nehmo¹Anthony Sonn¹Gael Moquin-Beaudry²Basma Benabdallah³Oanh Le³Christian Beausejour^1,3*

• ¹Universite de Montreal, Montreal, Canada
• ²Gustave Roussy, Villejuif, France
• ³Centre de Recherche du Centre Hospitalier Universitaire Sainte-Justine, Montreal, Canada

ABSTRACT Syngeneic mouse tumor models have shown that senescence influences the tumor immune response in multiple ways, including the induction of an immunosuppressive microenvironment or the promotion of immune cell recruitment. Yet, the impact of senescence on the tumor immune response in a humanized setting remains largely unexplored. To address this, we employed tumor spheroids and mice bearing tumors immunogenic to human immune cells derived from the same donor. We found that senescent fibroblasts exert a dual effect by enhancing the recruitment of immune cells into the tumor microenvironment while simultaneously promoting the apoptosis of T and NK cells. Mechanistically, we demonstrate that this apoptosis is primarily due to increased Fas ligand (FasL) expression on the surface of senescent fibroblasts. Deletion of FasL on fibroblasts was sufficient to prevent immune cell death and increase tumor cell killing. Our results highlight the importance of evaluating the impact of therapy-induced senescence in humanized models to understand and predict the outcome of cancer treatments.